- Name: TENSIVE SRL
- Innovative SME
- Website: tensivemed.com
- Market: Private Markets
- Main Currency: € - Euro
- Useful Links: startupitalia.eu | tensivemed.com
- Share Price: -
- Market Cap: -
- Location: Milano, Italy
Research and experimental development on biotechnology
Summary
1 Rounds
€ 14 million raised
Funding History
- Feb 2025 -> raised € 14 million in a Series A round.
*Funding rounds data on this chart is as accurate as possible and provide a fair valuation according to the market. Other data points are estimates based on kpis that are the most relevant to the company.
Income Statement
A.
TOTAL PRODUCTION VALUE 580,586€
A.5.
Total other revenues 580,586€
-- > other revenues of which contributions for operating expenses 509,468€
Other revenues 71,118€
B.
PRODUCTION COSTS 5,650,711€
B.6.
Purchase of materials 148,019€
B.7.
Services 3,135,812€
B.8.
Leased assets 221,585€
B.9.a.
wages/salaries 1,354,733€
B.9.b.
Social security costs 384,863€
B.9.c.
Severance payments 86,432€
B.9.e.
Other costs 65,811€
B.9.
c+d+e severance payments + pensions + other costs 152,243€
B.9.
TOT staff costs 1,891,839€
B.10.a.
Depreciation of intangibles 110,461€
B.10.b.
Depreciation of tangibles 123,318€
B.10.a.+b.+c.
Depreciation and impairment of fixed assets 233,779€
B.10.
TOT depreciation and impairment 233,779€
B.14.
Other operating charges 19,677€
*
Difference between value and cost of production (a - b) -5,070,125€
C.
TOTAL REVENUES AND FINANCIAL CHARGES 39,393€
C.16.c.
Revenues from current securities 41,402€
C.16.b.+c.
Revenues from securities 41,402€
C.16.d.
Other revenues 8,651€
C.16.d.
Other 8,651€
C.16.
Total other revenues 50,053€
C.17.
To other 10,032€
C.17.bis.
Profit and loss from foreign-exchange -628€
C.17.
Total financial charges 10,032€
*
Result before taxes -5,030,732€
21.
PROFIT/LOSS FOR THE YEAR -5,030,732€
Balance Sheet
B.
TOTAL FIXED ASSETS 1,302,429€
B.I.
TOTAL INTANGIBLE FIXED ASSETS 620,094€
B.I.1.
Startup/Expansions 2,617€
B.I.3.
Patents 502,861€
B.I.4.
Permits and licenses 37,750€
B.I.7.
Others 76,867€
B.II.
TOTAL TANGIBLE FIXED ASSETS 626,301€
B.II.2.
Plants and machinery 476,508€
B.II.3.
Industrial equipment 87,482€
B.II.4.
Other goods 45,692€
B.II.5.
Assets under construction and payments on account 16,618€
B.III.>>
SHORT TERM FINANCIAL CREDITS 56,034€
B.III.
TOTAL FINANCIAL FIXED ASSETS 56,034€
B.III.2.d-bis.
Credits to others 56,034€
B.III.2.d-bis.
Total credits to others 56,034€
B.III.2.
TOTAL CREDITS FINANCIAL FIXED ASSETS 56,034€
C.
CURRENT ASSETS 4,107,697€
C.II.
TOTAL CREDITS 1,210,230€
C.II.>>
SHORT TERM CREDITS 877,371€
C.II.>>
CREDITS DUE BEYOND THE NEXT FINANCIAL YEAR 331,127€
C.II.4.bis.
Tax assets 875,701€
C.II.4.bis.
Tax assets due beyond the next financial year 331,127€
C.II.4.bis.
Total tax assets 1,206,828€
C.II.5.
Credits to others 1,670€
C.II.5.
Total credits to others 1,670€
C.II.5.ter.
Total credits for prepaid taxes 1,731€
C.III.
TOTAL FINANCIAL ASSETS 2,351,077€
C.III.6.
Other securities 2,351,077€
C.IV.
Cash equivalents 546,390€
C.IV.1.
Bank deposits 546,390€
D.
Accruals and deferrals 70,919€
Total assets 5,481,045€
A.
TOTAL NET WORTH 4,154,649€
A.I.
Share capital 42,036€
A.II.
Share premium reserve 1,618,261€
A.VI.
Other reserves 7,525,084€
A.IX.
Profit/Loss for the year -5,030,732€
C.
Severance payments 122,170€
D.
TOTAL DEBTS 1,024,432€
D.>>
SHORT TERMS DEBTS 1,010,514€
D.>>
DEBTS DUE BEYOND THE NEXT FINANCIAL YEAR 13,919€
D.4.
Total debts owed to banks 17,661€
D.4.
Debts owed to banks 3,742€
D.4.
Debts owed to banks due beyond the next financial year 13,919€
D.7.
Total trade debts 742,333€
D.7.
Debts owed to suppliers 742,333€
D.12.
Tax liabilities 43,116€
D.12.
Total tax liabilities 43,116€
D.13.
Debts owed to social security agencies 106,596€
D.13.
Total debts due to social security and welfare institutions 106,596€
D.14.
Total other debts 114,727€
D.14.
Other debts 114,727€
E.
ACCRUALS AND DEFERRALS 179,794€
TOTAL LIABILITIES 5,481,045€
Balance Sheet History
Click on a year to load the balance sheet
⚠️ Data Normalization Applied ⚠️
Some values in this chart have been scaled down to improve readability when datasets have significantly different scales. Normalized data is indicated by dashed lines and diagonal striped bars.
Some values in this chart have been scaled down to improve readability when datasets have significantly different scales. Normalized data is indicated by dashed lines and diagonal striped bars.
*Data displayed on this chart is taken from the company's balance sheets and is as accurate as it can get. Balance sheets are normally filed once per year, so this Chart can take some time to get up to date.
Comments & Discussion
Loading comments...